What does the Craniosynostosis Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of multiple genes known to cause syndromic and isolated craniosynostosis.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth Next-Generation Sequencing supported by expert bioinformatic analysis to detect clinically significant variants.
Who should consider taking this test at Metropolis Healthcare?
Infants or children with abnormal head shape, early suture fusion, or suspected craniofacial syndromes may benefit.
What type of sample is needed for this panel at Metropolis Healthcare?
A blood sample collected in an EDTA tube is required for sequencing.
How can this test help in clinical management?
It helps confirm the genetic cause, supports surgical decision-making, and assists in long-term neurodevelopmental planning.
How long does Metropolis Healthcare take to provide the report?
The typical turnaround time is 2–4 weeks depending on sequencing complexity.
Can this panel identify carriers of craniosynostosis-related mutations?
Yes, it can detect carriers, which is useful for family planning and recurrence risk assessment.
Is genetic counseling recommended after this test at Metropolis Healthcare?
Yes, counseling helps interpret results, understand inheritance patterns, and guide future planning.